Search for: "Eli Lilly "
Results 181 - 200
of 2,153
Sorted by Relevance
|
Sort by Date
28 Jun 2018, 2:45 am
Sara MoranFollowing its denial of Actavis’ claim for declarations of non-infringement in respect of Eli Lilly’s European Patent, the Court of Appeal ruled on a number of procedural matters arising from that judgment. [read post]
8 Nov 2011, 3:46 pm
The deal resolves outstanding litigation Amylin launched earlier this year against Lilly and ends an almost decade-long partnership formed to develop and sell the diabetes drug Byetta. [read post]
8 Oct 2008, 4:25 pm
Here's an excerpt: Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly... [read post]
19 Jul 2011, 5:58 am
Eli Lilly & Co. said patients with Alzheimer’s disease whose conditions worsened upon taking the experimental drug semagacestat didn’t improve after dosing was halted. [read post]
21 Mar 2017, 5:05 am
As compensation, Eli Lilly sought at least $500 million in damages. [read post]
10 Dec 2009, 9:50 pm
Eli Lilly & Co. [read post]
8 Oct 2008, 6:35 am
Zyprexa is Lilly's biggest product, with global sales of $4.76 billion in 2007.The settlement with 32 states and the District of Columbia ends an 18-month investigation of the Indianapolis-based company, which had been accused of promoting the drug for unapproved off-label uses and of playing down side effects such as weight gain, which can increase the risk for diabetes.Source here. [read post]
1 Oct 2008, 8:46 pm
Eli Lilly is in talks with ImClone Systems about buying the maker of the cancer-fighting drug Erbitux for $6.1 billion, a person briefed on the matter said. [read post]
24 Aug 2012, 2:57 pm
Eli Lilly responded with an infringement suit against the generics makers. [read post]
8 Oct 2008, 4:13 pm
Updating earlier ILB Lilly Zyprexa entries, Tom Murphy and Marley Seaman of the Associated Press report today in a story that begins:Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday with several states, including Illinois, but several other storms are still brewing for the anti-psychotic medication. [read post]
2 Aug 2010, 5:00 am
Eli Lilly and Company (Fed. [read post]
27 Aug 2012, 11:01 am
Eli Lilly & Co. v. [read post]
31 Dec 2014, 7:01 am
Eli Lilly and Co., December 29, 2014, Marcus, S.). [read post]
22 Dec 2006, 3:43 am
Eli Lilly press release on New York Times story. [read post]
21 Aug 2009, 2:50 pm
Eli Lilly and Co. warrants en banc consideration. [read post]
4 Apr 2017, 2:51 am
Even though IP rights have been mentioned in IIAs as protected investments for decades, Eli Lilly v. [read post]
2 Jan 2007, 4:25 pm
From the December 20, 2006 issue of the NY Times: "A federal court in Brooklyn overseeing product liability lawsuits against Eli Lilly's best-selling drug Zyprexa has ordered the lawyer who provided company documents to The New York Times and other... [read post]
7 Jan 2014, 2:15 pm
'With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations,' said Derica Rice, Lilly executive vice president, global services and chief financial officer. [read post]
12 Sep 2017, 7:28 am
STAT reports on the “irony” in a ruling by a federal appeals court that Eli Lilly shouldn’t have stopped disability benefits for a former human resources executive with fibromyalgia when the company was marketing Cymbalta for the same condition. [read post]
10 Mar 2009, 1:26 pm
U.S. drug maker Eli Lilly is close to settling criminal and civil charges that it promoted a drug, Zyprexa, for unauthorized uses.The company is expected to settle the claims for $1.4 billion, according to reports on Wednesday.The company was charged with promoting the drug, an anti-psychotic, for use among children and the elderly, although it was not approved for use with those categories of patients.For the elderly, the company promoted the drug to nursing homes to calm patients… [read post]